Information TechnologyCompany
Select ImmunoGenomics Ownership
Who owns Select ImmunoGenomics?
Select ImmunoGenomics is owned by GeneCentric Therapeutics. It was acquired on August 15, 2019.
Select ImmunoGenomics Business Overview
Where is Select ImmunoGenomics headquartered?
Select ImmunoGenomics is headquartered in Apex, North Carolina.
What sector is Select ImmunoGenomics in?
Select ImmunoGenomics is an information technology company.
Information Technology M&A Summary in 2019
Out of 60 sectors in the Mergr database, information technology ranked 1 in number of deals in 2019. The largest information technology acquisition in 2019 was Total System Services - which was acquired by Global Payments for $21.5B.
Join Mergr to view all 825 acquisitions of information technology companies in 2019, including 110 acquisitions by private equity firms, and 715 by strategics.